Head of Machine Learning @intrepidlabsai | Previously @valence_ai and @recursionpharma | Neuroscience PhD @ccig_cambridge
Montreal, Quebec
Joined February 2011
- Tweets265
- Following177
- Followers184
- Likes571
Pinned Tweet
Thrilled to join @intrepidlabsai as Head of ML! We’re strengthening our AI platform with next-gen, purpose-built methods for pharma. Formulation is under-served by AI yet crucial to clinical success, we’re changing that so more medicines reach patients.
Michael Craig retweeted
We’re excited to share that our CEO and Co-Founder, @ChristineAllenW, has been named to the @medicine_maker’s 2026 Power List in the Small Molecules category, marking her second consecutive year on the list.
Congratulations, Christine! 🎉
#MedicineMakerPowerList #SmallMolecules
Michael Craig retweeted
Next week at #ICML2026, @craigmichaelm will present Intrepid’s work on agentic systems for sample-efficient drug formulation design.
The key result: the system identified a high-performing formulation in 1 batch vs. 4 for a Bayesian optimization baseline - ~4× fewer experiments.
Michael Craig retweeted
When Intrepid Labs works with pharma and biotech teams, the goal is to become an extension of the scientific team driving the program.
Better tools matter, but outcomes come from building them into real workflows, with the right expertise around the table.
#BIO2026 #AIinPharma
Michael Craig retweeted
🌐 Next week, Intrepid Labs heads to #DCAT2026.
On June 10, @ChristineAllenW gives a keynote on digital tools for durable transformation, then joins Andy Lewis of @Quotient_Sci to demonstrate how these principles can be applied in practice.
🗓️: dcat.org/summitagenda/ @dcatorg
Great to see Intrepid Labs featured here.
Formulation is a critical bottleneck in drug development. It is a complex, high-dimensional problem with tight constraints and a lot of reliance on trial and error. It's been really exciting to see how ML can start to change this by enabling more structured exploration, better data use, and faster iteration.
💡Formulation is one of the most underappreciated bottlenecks in drug development.
We’re building AI + robotics to rethink it at Intrepid Labs.
Proud to be recognized by @lifesciencesrev as a Top Drug Discovery & Development Company in Canada!
🔗 lifesciencesreview.com/intre…
Michael Craig retweeted
💡Formulation is one of the most underappreciated bottlenecks in drug development.
We’re building AI + robotics to rethink it at Intrepid Labs.
Proud to be recognized by @lifesciencesrev as a Top Drug Discovery & Development Company in Canada!
🔗 lifesciencesreview.com/intre…
Michael Craig retweeted
Being #digitalbydesign means capturing more than just formulations.
As Dr. Pauric Bannigan, CSO, explains, it’s about the full context, process parameters, environment, and metadata to make better decisions and enable smoother scale-up.
#AIinPharma #DrugFormulation
Michael Craig retweeted
🚀Intrepid Labs is featured in @torontolife's roundup of 20 mind-blowing inventions changing the world.
Read the full feature: torontolife.com/deep-dives/s…
Michael Craig retweeted
🔬 Insights from #AMLD2026
🔹Foundation models are moving beyond prediction toward actionable solutions across design spaces
🔹Robotics (from lab systems to humanoids) is increasingly embedded in real workflows
🔹Biology is becoming more model-driven, enabling deeper simulation
Michael Craig retweeted
⚙️ How do #AI and automation work together to transform drug formulation?
Dr. Riley Hickman, Sr. Director of Engineering, explains how pairing automated labs with AI enables scalable formulation workflows that continuously improve through iteration.
#AutonomousLabs
From February 10–12, Riley Hickman and I will be in Lausanne for the AMLD Intelligence Summit. Really looking forward to conversations about how autonomous labs can learn, adapt, and build lasting knowledge over time. AMLD is a great venue to connect with people across pharma and AI to better understand what it truly takes to deploy these systems safely and at scale in regulated pharmaceutical environments.
🧠 Looking ahead to #AMLD2026 @appliedmldays
Feb 10-12, @craigmichaelm and Riley Hickman will be discussing:
🔹 Autonomous labs as continual-learning systems
🔹 LLMs as orchestration layers
🔹 Scalable, regulation-ready AI for pharma
If you’ll be there, we’d love to connect!
Michael Craig retweeted
🧠 Looking ahead to #AMLD2026 @appliedmldays
Feb 10-12, @craigmichaelm and Riley Hickman will be discussing:
🔹 Autonomous labs as continual-learning systems
🔹 LLMs as orchestration layers
🔹 Scalable, regulation-ready AI for pharma
If you’ll be there, we’d love to connect!
Michael Craig retweeted
⭐ While #drugdiscovery has become increasingly digital, formulation remains largely analog.
Our CSO shares how Intrepid is building #AI-driven, robotic formulation workflows so promising molecules can reach patients faster.
Innovation with impact.
Michael Craig retweeted
🔍 A closer look at our poster at #NeurIPS2025!
We presented the first LLM baselines on an open SEDDS dataset and showed how LLMs can act as adaptable, context-driven virtual instruments that support more intelligent, iterative formulation design.
🎥 Walkthrough below.
Michael Craig retweeted
🔬 Today at #NeurIPS2025!
We’re presenting recent work on using #LLMs as Virtual Instruments for Drug Formulation. Riley Hickman & @craigmichaelm show how models reason from “formulation cards” to predict SEDDS outcomes, adding adaptability to formulation science.
Michael Craig retweeted
🌍 Next stop: Vienna.
We’ll be at #BIOEurope2025 Nov 3–5! 🚀 We’re excited to connect with biotech & pharma leaders at this global forum, exploring how deep formulation expertise, automation, and AI can accelerate drug development.
#DrugDevelopment #AI
Excited to share that @intrepidlabsai has partnered with @Mila_Quebec!
This collaboration connects our AI-driven formulation R&D with one of the world’s top hubs for machine learning and applied research.
🔔 We’re thrilled to share that Intrepid Labs is joining the @Mila_Quebec community, one of the world’s largest hubs for AI research & innovation. Together, we will continue to push the boundaries of AI-driven drug formulation. #Mila #AI
mila.quebec/en/news/mila-par…
Michael Craig retweeted
AI + automation are reshaping drug formulation. 🚀
Christine Allen shares how to:
✔️ Expand design space
✔️ Build scalability in early
✔️ Strengthen supply chains
✔️ Put patients first
Read the blueprint for pharma success 👉 ow.ly/gmqJ50X0UU3
#Pharma #DrugDevelopment #AI
Pharma formulation is shifting towards AI-driven design. Active learning + automation expand the design space, optimize for scale-up, cost & supply resilience. Summary of key ideas from @ChristineAllenW .
💡 We’re at an inflection point where AI is expanding what’s possible in formulation science.
In @medicine_maker, @ChristineAllenW shares the blueprint for AI-driven formulation success.
👉 themedicinemaker.com/issues/…
Michael Craig retweeted
💡 We’re at an inflection point where AI is expanding what’s possible in formulation science.
In @medicine_maker, @ChristineAllenW shares the blueprint for AI-driven formulation success.
👉 themedicinemaker.com/issues/…